SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of June 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on June 18, 2019. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No financial data or comparative analysis is included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to administrative details and the inclusion of a press release as Exhibit 99.1, the text of which is not provided.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing date is June 18, 2019, covering the month of June 2019.
- The filing includes a press release (Exhibit 99.1) which likely contains the substantive information, but the text of the release is not included in the source data.
- No financial figures are present in the provided text segment.